Английская Википедия:BPI-16350
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Orphan Шаблон:Infobox drug
BPI-16350 is a small molecule CDK4/6 inhibitor that is being studied for the treatment of cancer.[1][2] It has a similar structure to abemaciclib but is more selective for CDK4/6 over CDK9 according to preclinical research.[3]
References